AstraZeneca PLC Total Voting Rights (3197U)
April 01 2021 - 10:00AM
UK Regulatory
TIDMAZN
RNS Number : 3197U
AstraZeneca PLC
01 April 2021
1 April 2021 15:00 BST
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK
Financial Conduct Authority's Disclosure and Transparency Rule
5.6.1. As at 31 March 2021 the issued share capital of AstraZeneca
PLC with voting rights is 1,312,738,153 ordinary shares of US$0.25.
No shares are held in Treasury. Therefore, the total number of
voting rights in AstraZeneca PLC is 1,312,738,153.
The above figure for the total number of voting rights may be
used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change to their interest in, AstraZeneca PLC
under the UK Financial Conduct Authority's Disclosure and
Transparency Rules.
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led
biopharmaceutical company that focuses on the discovery,
development and commercialisation of prescription medicines,
primarily for the treatment of diseases in three therapy areas -
Oncology, Cardiovascular, Renal & Metabolism, and Respiratory
& Immunology. Based in Cambridge, UK, AstraZeneca operates in
over 100 countries and its innovative medicines are used by
millions of patients worldwide. Please visit astrazeneca.com and
follow the Company on Twitter @ AstraZeneca .
Contacts
For details on how to contact the Investor Relations Team,
please click here . For Media contacts, click here .
Adrian Kemp
Company Secretary
AstraZeneca PLC
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVRFLFIISRILIIL
(END) Dow Jones Newswires
April 01, 2021 10:00 ET (14:00 GMT)
Astrazeneca (LSE:0A4J)
Historical Stock Chart
From Apr 2024 to May 2024
Astrazeneca (LSE:0A4J)
Historical Stock Chart
From May 2023 to May 2024